1. July 2022 Pipeline BIT Pharma Announces Positive Phase 2b Study Results for NicaPlant® in aneurysmal subarachnoid heamorrhage patients (aSAH) undergoing aneurysm clipping.
6. July 2019 Pipeline BIT PHARMA ANNOUNCES SUCCESSFUL COMPLETION OF NicaPlant PHASE IIa CLINICAL TRIAL